Home/Filings/4/0001567619-21-017925
4//SEC Filing

Feigal Ellen 4

Accession 0001567619-21-017925

CIK 0001661059other

Filed

Oct 4, 8:00 PM ET

Accepted

Oct 5, 4:08 PM ET

Size

7.4 KB

Accession

0001567619-21-017925

Insider Transaction Report

Form 4
Period: 2021-10-01
Feigal Ellen
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-10-01+28,50028,500 total
    Exercise: $7.56Exp: 2031-09-30Common Stock (28,500 underlying)
  • Award

    Stock Option (Right to Buy)

    2021-10-01+10,38410,384 total
    Exercise: $7.56Exp: 2031-09-30Common Stock (10,384 underlying)
Footnotes (2)
  • [F1]The option vests in three equal annual installments beginning on October 1, 2021.
  • [F2]The option vests in full on the earlier of June 24, 2022 and the date of the 2022 Annual Meeting of Stockholders.

Documents

1 file

Issuer

NextCure, Inc.

CIK 0001661059

Entity typeother

Related Parties

1
  • filerCIK 0001758108

Filing Metadata

Form type
4
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 4:08 PM ET
Size
7.4 KB